Streetbeat News

Products Services

GLOV

The Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF (GLOV) is a smart beta ETF that offers broad exposure to the Broad Developed World ETFs category. It was launched on March 15, 2022.

Portfolio Pulse from

December 16, 2024 | 12:30 pm

USNZ

The Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USNZ) is a smart beta ETF that launched on June 28, 2022, providing broad exposure to the All Cap Blend category.

Portfolio Pulse from

December 16, 2024 | 12:30 pm

GSSC

The Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) is a smart beta ETF providing exposure to the Small Cap Blend category, launched on June 28, 2017.

Portfolio Pulse from

December 16, 2024 | 12:30 pm

ENVX

Enovix is poised to benefit from the launch of Android XR due to its advanced battery technology, a strategic agreement with a leading XR company, and a partnership with Qualcomm. The company's recent capital raise could enhance production capacity to meet potential demand.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

TUD

Tudor Gold Corp. has released an updated Mineral Resource Estimate for its Treaty Creek project, showing significant increases in gold, silver, and copper resources. This update is part of their 2024 exploration and technical programs.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

GDTRF

Gladiator Metals Corp announced promising drill results from its maiden drill program on the Arctic Chief Trend, part of the Whitehorse Copper Belt. The results include significant copper intersections, indicating potential for further exploration success.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

AMRN

Amarin Corporation has received national reimbursement approval for its drug VAZKEPA® (icosapent ethyl) in Italy. This approval allows the drug to be reimbursed for reducing cardiovascular risk in eligible high-risk patients. Italy is the third EU5 market to grant such reimbursement, marking the ninth national reimbursement for VAZKEPA® in Europe.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

LRMR

Larimar Therapeutics announced positive initial data from its ongoing long-term open-label extension study for nomlabofusp, a treatment for Friedreich's Ataxia. The study involves daily subcutaneous injections and shows promising results.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

HEVI

Helium Evolution Incorporated (HEVI) announced preliminary test results from its 10-1 helium discovery well in southern Saskatchewan, where it holds a 20% working interest in partnership with North American Helium Inc.

Portfolio Pulse from

December 16, 2024 | 12:15 pm

ELVA

Electrovaya Inc. has announced that its Infinity Series Lithium Ion Phosphate (LFP) based cell has achieved UL2580 recognition, highlighting the safety and reliability of its battery technology.

Portfolio Pulse from

December 16, 2024 | 12:15 pm